The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Acquisitions have the potential to add at least $1 billion in sales by 2028
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
Subscribe To Our Newsletter & Stay Updated
